| bibliographicCitation |
Narayan S, Carlson EM, Cheng H, Du H, Hu Y, Jiang Y, Lewis BM, Seletsky BM, Tendyke K, Zhang H, Zheng W, Littlefield BA, Towle MJ, Yu MJ. Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorganic & Medicinal Chemistry Letters. 2011 Mar;21(6):1630–3. doi: 10.1016/j.bmcl.2011.01.111. |